Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens.
第一作者:
Belén,Blanco
第一单位:
Servicio de Hematología, Hospital Universitario de Salamanca and Centro de Investigación del Cáncer/IBMCC (CIC/CSIC) Salamanca, Spain. belen_blancod@yahoo.es
作者:
主题词
抗肿瘤药(Antineoplastic Agents);硼酸化物(Boronic Acids);巨细胞病毒(Cytomegalovirus);巨细胞病毒感染(Cytomegalovirus Infections);剂量效应关系, 药物(Dose-Response Relationship, Drug);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);干扰素γ(Interferon-gamma);淋巴细胞活化(Lymphocyte Activation);淋巴细胞去除术(Lymphocyte Depletion);吡嗪类(Pyrazines);T淋巴细胞(T-Lymphocytes);移植, 同种(Transplantation, Homologous)
DOI
10.1016/j.leukres.2011.05.018
PMID
21658766
发布时间
2015-11-19
- 浏览17

Leukemia research
1412-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文